LDR Announces FDA Approval of Lateral Lumbar Cage System

LDR, a privately held spinal implant company, received FDA 510(k) clearance to market the Avenue L Lateral Lumbar Cage System.

Advertisement

Avenue L features enhanced in-line, self-guided VerteBRIDGE plating technology to facilitate cage insertion and zero-profile, intradiscal, integrated fixation through a direct, minimally invasive approach.

The Avenue L lateral cage has been used in Europe since 2010 with over 300 cases completed.

More Articles on Orthopedic Devices:

Bioimplants Market to Reach $134B

Judge Rejects Orthofix’s Settlement Over Medicare Fraud Case

DePuy Wins Patent for Spine Cage Instruments

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Watch On-Demand Webinar

ASC development + private equity: How to build value from day one

Presenters: Andrew HrankaWendy Bruno Thomson, MBA, LHARichard Romero, CVA, ABV, FHFMA, PAHM

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.